1. Home
  2. MBI vs ZNTL Comparison

MBI vs ZNTL Comparison

Compare MBI & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MBIA Inc.

MBI

MBIA Inc.

HOLD

Current Price

$6.51

Market Cap

312.7M

Sector

Finance

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$4.86

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBI
ZNTL
Founded
1973
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.7M
289.0M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MBI
ZNTL
Price
$6.51
$4.86
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$8.00
$6.60
AVG Volume (30 Days)
310.0K
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
62.04
18.03
EPS
N/A
N/A
Revenue
$80,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
90.48
N/A
52 Week Low
$4.41
$1.21
52 Week High
$8.26
$6.95

Technical Indicators

Market Signals
Indicator
MBI
ZNTL
Relative Strength Index (RSI) 57.09 64.59
Support Level $6.42 $3.53
Resistance Level $6.94 $5.11
Average True Range (ATR) 0.24 0.38
MACD 0.03 0.11
Stochastic Oscillator 65.50 81.88

Price Performance

Historical Comparison
MBI
ZNTL

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. The U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiaries.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: